Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does VentriPoint Diagnostics Ltd (VPT) operate in?
VentriPoint Diagnostics Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is VentriPoint Diagnostics Ltd (VPT) current stock price?
As of the latest data, VentriPoint Diagnostics Ltd stock price is CA$0.10, with a previous close of CA$0.09. VentriPoint Diagnostics Ltd gained CA$0.01 in the last trading session, representing a 5.56% increase.
What is VentriPoint Diagnostics Ltd (VPT) current market capitalization?
VentriPoint Diagnostics Ltd market cap is approximately 18.32 million.
What is VentriPoint Diagnostics Ltd (VPT) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.01.
Does VentriPoint Diagnostics Ltd (VPT) pay dividends?
No. VentriPoint Diagnostics Ltd does not pay a dividend.
When is VentriPoint Diagnostics Ltd (VPT) next earnings report?
VentriPoint Diagnostics Ltd is expected to release its next earnings report on September 30, 2026.
What is VentriPoint Diagnostics Ltd (VPT) beta (volatility) score?
VentriPoint Diagnostics Ltd has a beta of 0.200, indicating lower volatility than the overall market.
